DNA Methylation as a Biomarker for Cardiovascular Disease Risk

被引:289
|
作者
Kim, Myungjin [1 ,2 ]
Long, Tiffany I. [1 ,2 ]
Arakawa, Kazuko [1 ,2 ]
Wang, Renwei [3 ]
Yu, Mimi C. [3 ]
Laird, Peter W. [1 ,2 ]
机构
[1] Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA
[2] Univ So Calif, Dept Biochem & Mol Biol, Keck Sch Med, Los Angeles, CA 90033 USA
[3] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
来源
PLOS ONE | 2010年 / 5卷 / 03期
关键词
S-ADENOSYLHOMOCYSTEINE; PLASMA HOMOCYSTEINE; EXPRESSION; HYPOMETHYLATION; ATHEROSCLEROSIS; PATTERNS; MICE;
D O I
10.1371/journal.pone.0009692
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Elevated serum homocysteine is associated with an increased risk of cardiovascular disease (CVD). This may reflect a reduced systemic remethylation capacity, which would be expected to cause decreased genomic DNA methylation in peripheral blood leukocytes (PBL). Methodology/Principal Findings: We examined the association between prevalence of CVD (myocardial infarction, stroke) and its predisposing conditions (hypertension, diabetes) and PBL global genomic DNA methylation as represented by ALU and Satellite 2 (AS) repetitive element DNA methylation in 286 participants of the Singapore Chinese Health Study, a population-based prospective investigation of 63,257 men and women aged 45-74 years recruited during 1993-1998. Men exhibited significantly higher global DNA methylation [geometric mean (95% confidence interval (CI)): 159 (143, 178)] than women [133 (121, 147)] (P= 0.01). Global DNA methylation was significantly elevated in men with a history of CVD or its predisposing conditions at baseline (P= 0.03) but not in women (P= 0.53). Fifty-two subjects (22 men, 30 women) who were negative for these CVD/predisposing conditions at baseline acquired one or more of these conditions by the time of their follow-up I interviews, which took place on average about 5.8 years post-enrollment. Global DNA methylation levels of the 22 incident cases in men were intermediate (AS, 177) relative to the 56 male subjects who remained free of CVD/predisposing conditions at follow-up (lowest AS, 132) and the 51 male subjects with a diagnosis of CVD or predisposing conditions reported at baseline (highest AS 184) (P for trend = 0.0008) No such association was observed in women (P = 0.91). Baseline body mass index was positively associated with AS in both men and women (P= 0.007). Conclusions/Significance: Our findings indicate that elevated, not decreased, PBL DNA methylation is positively associated with prevalence of CVD/predisposing conditions and obesity in Singapore Chinese.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Differential DNA methylation in peripheral blood DNA as a biomarker of hepatocellular carcinoma risk
    Lubecka-Pietruszewska, Katarzyna
    Kurzava, Lucinda
    Buvala, Hannah
    Flower, Kirsty
    Gawrieh, Samer
    Mansfield, Jennifer
    Chalasani, Naga
    Flanagan, James M.
    Stefanska, Barbara
    CANCER RESEARCH, 2015, 75
  • [22] DNA methylation biomarkers of myocardial infarction and cardiovascular disease
    Alba Fernández-Sanlés
    Sergi Sayols-Baixeras
    Isaac Subirana
    Mariano Sentí
    S. Pérez-Fernández
    Manuel de Castro Moura
    Manel Esteller
    Jaume Marrugat
    Roberto Elosua
    Clinical Epigenetics, 2021, 13
  • [23] New insights into the role of DNA methylation in cardiovascular disease
    Bardi, Nicholas
    Carbone, Federico
    Montecucco, Fabrizio
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 (02)
  • [24] Arsenic Exposure, Blood DNA Methylation, and Cardiovascular Disease
    Domingo-Relloso, Arce
    Makhani, Kiran
    Riffo-Campos, Angela L.
    Tellez-Plaza, Maria
    Klein, Kathleen Oros
    Subedi, Pooja
    Zhao, Jinying
    Moon, Katherine A.
    Bozack, Anne K.
    Haack, Karin
    Goessler, Walter
    Umans, Jason G.
    Best, Lyle G.
    Zhang, Ying
    Herreros-Martinez, Miguel
    Glabonjat, Ronald A.
    Schilling, Kathrin
    Galvez-Fernandez, Marta
    Kent, Jack W., Jr.
    Sanchez, Tiffany R.
    Taylor, Kent D.
    Johnson, W. Craig
    Durda, Peter
    Tracy, Russell P.
    Rotter, Jerome I.
    Rich, Stephen S.
    Van Den Berg, David
    Kasela, Silva
    Lappalainen, Tuuli
    Vasan, Ramachandran S.
    Joehanes, Roby
    Howard, Barbara V.
    Levy, Daniel
    Lohman, Kurt
    Liu, Yongmei
    Fallin, M. Daniele
    Cole, Shelley A.
    Mann, Koren K.
    Navas-Acien, Ana
    CIRCULATION RESEARCH, 2022, 131 (02) : E51 - E69
  • [25] DNA Methylation: A Potential Biomarker of Chronic Obstructive Pulmonary Disease
    He, Lin-Xi
    Tang, Zhao-Hui
    Huang, Qing-Song
    Li, Wei-Hong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [26] DNA methylation and gene expression integration in cardiovascular disease
    Guillermo Palou-Márquez
    Isaac Subirana
    Lara Nonell
    Alba Fernández-Sanlés
    Roberto Elosua
    Clinical Epigenetics, 2021, 13
  • [27] Utility of DNA Methylation as a Biomarker in Aging and Alzheimer's Disease
    Milicic, Lidija
    Porter, Tenielle
    Vacher, Michael
    Laws, Simon M.
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2023, 7 (01) : 475 - 503
  • [28] DNA methylation and gene expression integration in cardiovascular disease
    Palou-Marquez, Guillermo
    Subirana, Isaac
    Nonell, Lara
    Fernandez-Sanles, Alba
    Elosua, Roberto
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [29] Apolipoprotein E DNA Methylation in Dementia and Cardiovascular Disease
    Karlsson, Ida K.
    Hagg, Sara
    Pedersen, Nancy L.
    GERONTOLOGIST, 2015, 55
  • [30] DNA methylation biomarkers of myocardial infarction and cardiovascular disease
    Fernandez-Sanles, Alba
    Sayols-Baixeras, Sergi
    Subirana, Isaac
    Senti, Mariano
    Perez-Fernandez, S.
    de Castro Moura, Manuel
    Esteller, Manel
    Marrugat, Jaume
    Elosua, Roberto
    CLINICAL EPIGENETICS, 2021, 13 (01)